Recursion Pharmaceuticals(MX:RXRX)
MX$66.700.00 (0.00%)
MX:RXRX
Recursion Pharmaceuticals earnings date
MX$66.70
At close:0.00 (0.00%)
Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings Report
7 Followers
MX:RXRX Q2 2025 EPS Results
- Actual EPS
- -MXN 7.63
- Consensus EPS
- -MXN 6.57
- Beat/Miss
- Missed by -MXN 1.06
- One Year Ago EPS
- -MXN 7.44
MX:RXRX Q2 2025 Revenue Results
- Actual Revenue
- MXN 357.60M
- Expected Revenue
- MXN 285.87M
- Beat/Miss
- Beat by +MXN 71.73M
- YoY Revenue Growth
- +33.34%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/05/2025
- Time
- Before Open
- Conference Call
- Tuesday, August 5, 2025
MX:RXRX Upcoming Earnings
Recursion Pharmaceuticals's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
MX:RXRX Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RXRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -3.79- | -3.91 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -4.07-4.09 | -6.7 | 38.89% (+2.60) | |
| Aug 05, 2026 | 2026 (Q2) | -4.46-4.65 | -7.63 | 39.02% (+2.98) | |
| May 06, 2026 | 2026 (Q1) | -4.93-4.09 | -9.3 | 56.00% (+5.21) | |
| Feb 25, 2026 | 2025 (Q4) | -5.60-3.91 | -9.86 | 60.38% (+5.95) | |
| Nov 05, 2025 | 2025 (Q3) | -7.01-6.70 | -6.32 | -5.88% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -6.57-7.63 | -7.44 | -2.50% (-0.19) | |
| May 05, 2025 | 2025 (Q1) | -9.60-9.30 | -7.26 | -28.21% (-2.05) | |
| Feb 28, 2025 | 2024 (Q4) | -7.65-9.86 | -7.81 | -26.19% (-2.05) | |
| Nov 06, 2024 | 2024 (Q3) | -6.19-6.32 | -8 | 20.93% (+1.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


